On that a probable connection between the efficacy of the EGFR-TKI-related therapy and overexpression of the lncRNA SOX2-OT and SOX2 protein has been associated with lung cancer cell proliferation and poor survival in a cohort that included 83 lung cancer patients [135]. Here, EGFR is linked to lung carcinoma.